Associated Papers
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors.
Guida M et al.
Pigment Cell & Melanoma Research, 2016
Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
Goldstein AM et al.
International Journal of Cancer, 2007
Select a paper to view details